Pharmacokinetics of dalbavancin in bone and associated tissues in patients undergoing orthopedic surgery

Trial Profile

Pharmacokinetics of dalbavancin in bone and associated tissues in patients undergoing orthopedic surgery

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Dalbavancin (Primary)
  • Indications Bacterial infections; Bone and joint infections; Postoperative infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Durata Therapeutics
  • Most Recent Events

    • 27 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top